A refractive surgeon encountering a vitreoretinal complication is at the boundary of their subspecialty. The outcome at that boundary depends entirely on whether a formal escalation pathway was established before it was needed.
The Structure of Ophthalmic Subspecialties
Ophthalmology is a multidisciplinary specialty: anterior segment, corneal, vitreoretinal, oculoplastic, glaucoma, and paediatric subspecialties each require distinct training and expertise. A surgeon whose primary practice is in refractive and cataract surgery does not carry equivalent depth in vitreoretinal management. This is the structure of subspecialisation, not a deficiency. ¹
In practical terms: No single ophthalmic surgeon can be expert across every subspecialty. What matters is not whether this boundary exists, it always does, but whether the pathway across it is designed in advance.
When Specialist Input Changes Outcomes
Scenarios in which vitreoretinal or other specialist input is directly relevant in refractive and anterior segment practice include:
- Posterior capsule rupture with vitreous prolapse – vitreoretinal skills are required for anterior vitrectomy and lens fragment management
- Unexpected posterior segment findings on preoperative or postoperative fundus imaging
- Persistent corneal haze not responding to medical management – anterior segment specialist
- Severe dry eye with corneal surface compromise – ocular surface subspecialist
In each scenario, timely access to the appropriate subspecialty is associated with better patient outcomes than delayed referral or self-managed care. ²
The Blue Fin Vision® Escalation Model
Professor Mahmut Dogramaci, Consultant Vitreoretinal Surgeon, is the named specialist colleague for cases at Blue Fin Vision® requiring posterior segment input. This is a formal clinical relationship with established referral and operating protocols.
When a referral becomes necessary, Professor Dogramaci receives the full clinical record, preoperative imaging, and surgical notes. The referral is not to an unknown system; it is to a named colleague with complete clinical context.
Blue Fin Vision® specifically: The formal relationship with Professor Dogramaci is established before any patient is treated at Blue Fin Vision®. The escalation pathway is a designed component of the clinical model, not a response to an event that has already occurred. This is the specific structural feature that distinguishes a designed system from a reactive one.
Why This Is Uncommon
Many commercial refractive providers operate as self-contained units. A patient experiencing a vitreoretinal complication may be referred to an NHS waiting list with no guarantee of timing, continuity, or shared clinical information. ³
When things are straightforward, many clinics perform well. When they are not, that is where systems, experience and accountability matter most.
Frequently Asked Questions
What is Professor Dogramaci’s role at Blue Fin Vision®?
Professor Mahmut Dogramaci is a Consultant Vitreoretinal Surgeon who is the named specialist escalation contact for Blue Fin Vision®. He is not a Blue Fin Vision® clinician, he is a formal specialist colleague. When cases require vitreoretinal input, he receives the full clinical record and manages the case with continuity of information.
Has Mr Hove needed to escalate a case to a specialist?
Yes. Over a career of more than 57,000 procedures, the clinical situations that require specialist input arise. What matters is that when they do, the pathway exists, the relationship is established, and the handover is complete rather than fragmented. This is the argument for designing the escalation pathway before it is needed.
Does every complication require specialist referral?
No. The majority of postoperative complications in refractive surgery, haze, residual refractive error, dry eye, healing delay, are managed within anterior segment expertise. Specialist referral is reserved for cases at or beyond the boundary of that expertise. The value of the escalation pathway is that when it is needed, it is available without delay.
References
- Urbach DR. Pledging to eliminate low-volume surgery. N Engl J Med. 2015;373(15):1388-1390.
- Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128-1137.
- Commission on Cancer. Cancer Program Standards 2012: Ensuring Patient-Centered Care. American College of Surgeons; 2012.
- Tufail A, Amoaku WM, Downey L, Ghanchi F, Johnston RL, McKibbin M, Menon G, Talks J, Sivaprasad S. Surgical outcomes in vitreoretinal surgery: a national audit. Eye. 2014;28(10):1166-1177.
- National Ophthalmology Database Audit. Cataract Surgery. The Royal College of Ophthalmologists; 2023.
Related Topics
- Corneal Haze After TransPRK
- When Things Are Not Perfect: Understanding Risk, Recovery and Responsibility
- What Happens If Something Goes Wrong After Laser Eye Surgery?
- Corneal Haze After PRK or TransPRK: Causes, Treatment, and Outcomes
- Is Corneal Haze Permanent After Laser Eye Surgery?
- When Results Are Suboptimal: Observation, Medical Treatment, or Enhancement
- How Often Do Serious Complications Occur in Laser Eye Surgery?
- Why Safe Eye Surgery Depends on Systems, Not Just a Good Surgeon
- The Blue Fin Vision® Advantage: How Our System Protects You
- Why Specialist Access Matters When Eye Surgery Gets Complicated
- What Happens If Your Surgeon Needs a Second Opinion?
- Patient Case: Corneal Haze After TransPRK – Messages, OCT, and Outcome
- When Recovery Doesn’t Go to Plan
- How Months-Long Follow-Up Changes Outcomes
- Does Laser Eye Surgery Always Go Perfectly?
- Why No Surgeon Can Guarantee Perfect Vision
- What Good Aftercare Looks Like After Laser Eye Surgery
- Are Enhancements Included After Laser Eye Surgery?
- When Is an Enhancement Needed?
- How Often Do Patients Need Enhancements?
- Why Most Clinics Don’t Talk Openly About Complications
- What Truly Separates Great Clinics When Things Go Wrong
